174 related articles for article (PubMed ID: 35517894)
1. Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.
Barinda AJ; Arozal W; Sandhiutami NMD; Louisa M; Arfian N; Sandora N; Yusuf M
Adv Pharm Bull; 2022 Jan; 12(1):128-141. PubMed ID: 35517894
[No Abstract] [Full Text] [Related]
2. Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1.
Zhang X; Liang D; Guo L; Liang W; Jiang Y; Li H; Zhao Y; Lu S; Chi ZH
Mol Med Rep; 2015 Jul; 12(1):1347-55. PubMed ID: 25823828
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
4. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.
Montopoli M; Ragazzi E; Froldi G; Caparrotta L
Cell Prolif; 2009 Apr; 42(2):195-206. PubMed ID: 19236381
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Liquiritigenin against Cisplatin-Induced Nephrotoxicity via NRF2/SIRT3-Mediated Improvement of Mitochondrial Function.
Zhou M; Dai Y; Ma Y; Yan Y; Hua M; Gao Q; Geng X; Zhou Q
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744945
[TBL] [Abstract][Full Text] [Related]
6. Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA.
Sandhiutami NMD; Arozal W; Louisa M; Rahmat D; Wuyung PE
Front Pharmacol; 2020; 11():603235. PubMed ID: 33536913
[TBL] [Abstract][Full Text] [Related]
7. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling.
Al Fayi M; Otifi H; Alshyarba M; Dera AA; Rajagopalan P
J Drug Target; 2020 Nov; 28(9):913-922. PubMed ID: 31983246
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
[TBL] [Abstract][Full Text] [Related]
10. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity.
Sahin K; Orhan C; Tuzcu M; Muqbil I; Sahin N; Gencoglu H; Guler O; Padhye SB; Sarkar FH; Mohammad RM
Biol Trace Elem Res; 2014 Feb; 157(2):156-63. PubMed ID: 24415068
[TBL] [Abstract][Full Text] [Related]
12. Curcumin prevents cisplatin-induced renal alterations in mitochondrial bioenergetics and dynamic.
Ortega-Domínguez B; Aparicio-Trejo OE; García-Arroyo FE; León-Contreras JC; Tapia E; Molina-Jijón E; Hernández-Pando R; Sánchez-Lozada LG; Barrera-Oviedo D; Pedraza-Chaverri J
Food Chem Toxicol; 2017 Sep; 107(Pt A):373-385. PubMed ID: 28698153
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer.
Bortot B; Mongiat M; Valencic E; Dal Monego S; Licastro D; Crosera M; Adami G; Rampazzo E; Ricci G; Romano F; Severini GM; Biffi S
Int J Nanomedicine; 2020; 15():4793-4810. PubMed ID: 32764921
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK.
Weir NM; Selvendiran K; Kutala VK; Tong L; Vishwanath S; Rajaram M; Tridandapani S; Anant S; Kuppusamy P
Cancer Biol Ther; 2007 Feb; 6(2):178-84. PubMed ID: 17218783
[TBL] [Abstract][Full Text] [Related]
16. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
17. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
18. Curcumin prevents cisplatin-induced decrease in the tight and adherens junctions: relation to oxidative stress.
Trujillo J; Molina-Jijón E; Medina-Campos ON; Rodríguez-Muñoz R; Reyes JL; Loredo ML; Barrera-Oviedo D; Pinzón E; Rodríguez-Rangel DS; Pedraza-Chaverri J
Food Funct; 2016 Jan; 7(1):279-93. PubMed ID: 26467482
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines.
Baribeau S; Chaudhry P; Parent S; Asselin É
PLoS One; 2014; 9(1):e86987. PubMed ID: 24466305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
